What is the exact renal mechanism of the diuretic action of nesiritide?

The provided sources do not describe the exact intrarenal mechanism of action of nesiritide. It is indicated that the drug binds to type A and B natriuretic peptide receptors, increases cGMP production, and decreases vascular wall tone. Its effects include natriuresis — an increase in the excretion of sodium ions in the urine — and diuresis.

What is the main stimulus for the production of natriuretic peptides?

The primary trigger is an increase in blood pressure (BP) or an increase in circulating blood volume (CBV), which leads to stretching of the heart and vascular walls.

Does nesiritide cause reflex tachycardia?

No. Unlike many other vasodilators, it does not provoke significant reflex tachycardia and does not increase blood norepinephrine levels.

How does nesiritide affect preload and afterload?

The drug is a balanced arteriovenous vasodilator. By dilating capacitance veins, it decreases preload, and by dilating resistance arteries, it decreases afterload on the heart.

Through which second messenger is the effect of these drugs mediated?

Relaxation of vascular smooth muscle occurs due to an increase in intracellular production of cGMP (cyclic guanosine monophosphate).

Natriuretic Peptides: Anatomy, Agonists and Mechanism

Natriuretic Peptides and Their Agonists

*Nesiritidum*

For medical students2 min readUpdated 2026-10-10

Natriuretic peptides are essential endogenous hemodynamic regulators produced by the body in response to elevated blood pressure or excessive increases in circulating blood volume. Their pharmacological agonists, exemplified by the recombinant drug Nesiritidum, are used in medicine to achieve powerful vasodilatory and diuretic effects without the risk of reflex tachycardia.

Site of synthesisType A is produced in the atria, type B in the ventricles, and type C in endothelial cells.

Target siteSpecific type A and B receptors on vascular smooth muscle cells.

Second messengerIncreased cGMP production leads to decreased smooth muscle tone.

Prototype drugNesiritide — a recombinant type B peptide for intravenous administration.

Physiological Role and Localization

The natriuretic peptide system is a natural physiological mechanism protecting the cardiovascular system from overload. The primary stimulus for the active production of these substances is an increase in blood pressure (BP) or a significant increase in circulating blood volume (CBV).

Depending on the anatomical site of synthesis, three main types of these compounds are distinguished in physiology:

Type A — produced predominantly in atrial myocytes.
Type B — synthesized in the ventricular myocardium.
Type C — produced by endothelial cells (cells lining the inner surface of blood vessels).
The key physiological effects of this system are a pronounced natriuretic action (enhanced excretion of sodium ions from the body) and a vasodilatory effect (dilation of blood vessels).

Molecular Mechanism of Action

The molecular mechanism of vasodilation characteristic of these substances is strictly specific. Both endogenous peptides themselves and their synthetic agonists bind to specific receptors (predominantly types A and B). These receptors are localized on the membranes of endothelial cells and vascular smooth muscle cells (angiocytes).

Stimulation of these receptors triggers an intracellular cascade of reactions that leads to a sharp increase in the production of cGMP (cyclic guanosine monophosphate). The intracellular accumulation of this second messenger ensures a reliable reduction in smooth muscle tone, which is clinically manifested by relaxation of the vascular wall.

Nesiritide as a Prototype Agonist

The prototype representative of the agonist group is nesiritide (Nesiritidum). Structurally, it is a recombinant B-type natriuretic peptide. The drug is intended exclusively for intravenous administration and possesses a unique hemodynamic profile.

Nesiritide acts as a balanced arteriovenous vasodilator, affecting different types of vessels:

It effectively dilates capacitance vessels (veins), leading to a reliable decrease in cardiac preload.
Simultaneously, the drug dilates resistance vessels (arteries), thereby reducing afterload.
As an additional, highly important effect, nesiritide dilates coronary vessels, improving myocardial blood supply.

A crucial feature of nesiritide's action is the absence of significant reflex tachycardia. Unlike many other vasodilators, it does not cause a compensatory increase in norepinephrine levels. Furthermore, the drug exerts a pronounced diuretic effect due to natriuresis. In clinical practice, it is well tolerated, and side effects are minor, usually limited to headache or hypotension.

Promising Myotropic Vasodilators

The pharmacology of myotropic agents is constantly evolving. The search for new myotropic vasodilators aims to create drugs capable of selectively targeting vascular tone.

Currently, several promising directions and drug groups are distinguished:

Natriuretic peptide analogs — the group that includes the recombinant nesiritide discussed above.
Endothelin receptor antagonists — agents that block receptors for a potent endogenous vasoconstrictor.
Vasopressin antagonists — drugs that eliminate the vasoconstrictor and antidiuretic effects of this hormone.

Mnemonic

To easily remember the site of peptide synthesis, use alphabetical order from top to bottom: A — Atria (upper chambers), B — Ventricles (lower chambers), C — Circulation/vessels (endothelial cells).

Frequently asked questions

What is the exact renal mechanism of the diuretic action of nesiritide?: The provided sources do not describe the exact intrarenal mechanism of action of nesiritide. It is indicated that the drug binds to type A and B natriuretic peptide receptors, increases cGMP production, and decreases vascular wall tone. Its effects include natriuresis — an increase in the excretion of sodium ions in the urine — and diuresis.
What is the main stimulus for the production of natriuretic peptides?: The primary trigger is an increase in blood pressure (BP) or an increase in circulating blood volume (CBV), which leads to stretching of the heart and vascular walls.
Does nesiritide cause reflex tachycardia?: No. Unlike many other vasodilators, it does not provoke significant reflex tachycardia and does not increase blood norepinephrine levels.
How does nesiritide affect preload and afterload?: The drug is a balanced arteriovenous vasodilator. By dilating capacitance veins, it decreases preload, and by dilating resistance arteries, it decreases afterload on the heart.
Through which second messenger is the effect of these drugs mediated?: Relaxation of vascular smooth muscle occurs due to an increase in intracellular production of cGMP (cyclic guanosine monophosphate).

Go deeper

Comparative characteristics of myocardial preload and afterload
The role of cGMP in the regulation of smooth muscle cell tone
Mechanisms of action of endothelin antagonists
Pharmacological effects of vasopressin antagonists